Concepedia

Publication | Open Access

BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i> -Mutant Thyroid Cancer

DOIFull Paper Access

226

Citations

28

References

2014

Year

Gerald S. Falchook, Michael Millward, David S. Hong, Aung Naing, Sarina A. Piha‐Paul, Steven G. Waguespack, Maria E. Cabanillas, Steven I. Sherman, Bo Ma, Martin Curtis,
Thyroid

Abstract

Dabrafenib was well tolerated and resulted in durable responses in BRAF-mutant differentiated thyroid carcinoma patients.

References

YearCitations

Page 1